Regeneron Announces Upcoming 2013 Investor Conference Presentations - WICU12/WSEE Erie, PA News, Sports, Weather and Events

Regeneron Announces Upcoming 2013 Investor Conference Presentations

  • Chris Lifestyle Category TEST

  • Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1
  • Monday, February 6 2012 4:05 PM EST2012-02-06 21:05:06 GMT
    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Regeneron Pharmaceuticals, Inc.

TARRYTOWN, N.Y., May 8, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • UBS Global Healthcare Conference on Monday, May 20, 2013.  The presentation is scheduled for 10:00 a.m. Eastern Time.
  • 38th Annual dbAccess Healthcare Conference on Wednesday, May 29, 2013.  The presentation is scheduled for 8:40 a.m. Eastern Time.
  • Jefferies 2013 Healthcare Conference on June 3, 2013.  The presentation is scheduled for 9:00 a.m. Eastern Time.
  • Goldman Sachs 34th Annual Global Healthcare Conference on Tuesday, June 11, 2013.  The presentation is scheduled for 11:40 a.m. Eastern Time (8:40 a.m. Pacific Time).

The presentations may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  An archived version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Contact Information:




Manisha Narasimhan, Ph.D.    

Peter Dworkin

Investor Relations             

Corporate Communications                           

914.847.5126             

914.847.7640             

manisha.narasimhan@regeneron.com  

peter.dworkin@regeneron.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
3514 State St. Erie, PA 16508
Newsroom: (814)454-8812
Toll Free: 1(800)454-8812
Business offices: (814)454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
Mobile:
Mobile Site
Be sure to stay constantly updated with the power of WICU12 and WSEE at your fingertips
Free Android App
Free iPhone App
Free iPad App
Storm Tracker App
Droid
iPhone
iPad
All content © Copyright 2000 - 2013 WorldNow and WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com